Summary
ZOM Chart
Zomedica Corp. (ZOMDF) Reports Q1 Loss, Lags Revenue Estimates
Zomedica Corp. (ZOMDF) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to loss of $0.01 per share a year ago.
Zomedica Corp. (ZOMDF) Q4 2024 Earnings Call Transcript
Zomedica Corp. (OTC:ZOMDF) Q4 2024 Earnings Conference Call March 13, 2025 4:30 PM ET Company Participants Mike Vallie – ICR Larry Heaton – Chief Executive Officer Scott Jordan – Executive Vice President and Chief Financial Officer Mike Zuehlke – Vice President of Finance and Corporate Controller Conference Call Participants Robert LeBoyer – Noble Capital Markets Robert Sassoon – Water Tower Research Andrew Rem – Odinson Partners Operator Good afternoon, ladies and gentlemen, and welcome to the Zomedica Fourth Quarter 2024 Financial Results Conference Call. At this time all lines are in listen-only mode.
Zomedica Appoints Scott A. Jordan Executive Vice President, Finance & Chief Financial Officer
Seasoned executive brings a broad skill set to Zomedica's leadership team ANN ARBOR, MI / ACCESSWIRE / December 19, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Scott A. Jordan as its Executive Vice President, Finance and Chief Financial Officer, effective January 1, 2025.
Zomedica Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 2,200 | $0.26 | $0.26 | - | - |
| CAL CoreCap Advisors LLC CoreCap Advisors LLC | 4,800 | $0.19 | $0.19 | - | - |
| TKP Tallon Kerry Patrick Tallon Kerry Patrick | 150,000 | $20,730 | $20,730 | - | - |
Zomedica Corp. (ZOM) FAQ
What does "Delisted" mean?
What was the last recorded dividend?
How long did the company pay dividends?
Were there any stock splits?
What was the last known trading price?
Zomedica Corp. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Larry C. Heaton II CEO | AMEX Exchange | 98980M109 CUSIP |
| US Country | 144 Employees | - Last Dividend | - Last Split | 29 Jul 2016 IPO Date |
Overview
Zomedica Corp. is a dedicated veterinary health company that addresses the unmet clinical needs of veterinarians. Focused on companion animals, Zomedica develops innovative products aimed at improving veterinary care. The company is committed to enhancing the capabilities of clinical practice through groundbreaking technology and solutions. Headquartered in Ann Arbor, Michigan, Zomedica was founded in 2015 and was previously known as Zomedica Pharmaceuticals Corp. In October 2020, the company rebranded itself to reflect its focus on veterinary health.
Products and Services
- TRUFORMA Platform
The TRUFORMA platform is an advanced point-of-care diagnostic system designed for veterinarians. It provides dynamic testing solutions for a variety of disease states affecting dogs and cats, enabling timely and informed decision-making in clinical practice.
- PulseVet
PulseVet offers therapeutic solutions for musculoskeletal conditions in both horses and small animals. This treatment addresses issues such as broken bones, tendonitis, and torn ligaments, helping to improve mobility and recovery for affected animals.
- Liquid Biopsy Assays
In collaboration with Celsee, Inc., Zomedica is developing and commercializing innovative liquid biopsy assays. These diagnostics aim to detect cancer in companion animals, leading to earlier and more effective treatment options for pets diagnosed with cancer.
- Pathogen Detection System
In partnership with Seraph Biosciences, Inc., Zomedica is working on a novel pathogen detection system. This system is designed to identify harmful pathogens in companion animals, enhancing diagnosis and treatment efficiency in veterinary practices.
